Form 4 Tracker
Kiniksa Pharmaceuticals International, plc
KNSA

43 insider filings · Latest: Sep 1, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Apr 14, 2025Apr 14 8:56 PMTessari Eben
Proposed Sale
12,000$20.49$245.9K—

View →

Mar 17, 2025Mar 17 9:29 PMRagosa Mark
Proposed Sale
36,287$23.10$838.2K—

View →

Mar 12, 2025Mar 12 8:47 PMMegna Michael R
Proposed Sale
9,051$22.45$203.2K—

View →

Mar 12, 2025Mar 12 8:04 PMRagosa Mark
Proposed Sale
36,372$22.25$809.4K—

View →

Mar 10, 2025Mar 10 9:13 PMTessari Eben
Proposed Sale
12,409$21.06$261.3K—

View →

Feb 10, 2025Feb 10 10:37 PMTessari Eben
Proposed Sale
14,000$19.57$274.0K—

View →

Jan 13, 2025Jan 13 10:27 PMTessari Eben
Proposed Sale
14,000$18.24$255.4K—

View →

Dec 16, 2024Dec 16 10:17 PMTessari Eben
Proposed Sale
23,017$20.44$470.4K—

View →

Dec 3, 2024Dec 3 10:25 PMRagosa Mark
Proposed Sale
72,754$21.25$1.5M—

View →

Nov 27, 2024Nov 27 10:13 PMMegna Michael R
Proposed Sale
17,697$22.45$397.3K—

View →

Nov 18, 2024Nov 18 10:50 PMTessari Eben
Proposed Sale
17,000$21.04$357.6K—

View →

Nov 6, 2024Nov 6 9:11 PMPatel Sanj K
Proposed Sale
89,561$23.00$2.1M—

View →

Oct 15, 2024Oct 15 8:57 PMTessari Eben
Proposed Sale
17,000$26.87$456.8K—

View →

Sep 23, 2024Sep 23 9:02 PMTessari Eben
Proposed Sale
17,500$24.99$437.3K—

View →

Sep 3, 2024Sep 3 9:17 PMMoat Ross
Proposed Sale
68,506$26.12$1.8M—

View →

Sep 3, 2024Sep 3 9:16 PMPaolini John F.
Proposed Sale
90,217$26.12$2.4M—

View →

Aug 27, 2024Aug 27 9:17 PMTessari Eben
Proposed Sale
17,500$26.91$470.9K—

View →

← Previous

Page 5 of 5

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 29, 2026Jun 2 8:48 PMTracey L MccainDirector
Grant/Award
14,184$48.382,026(D)

View →

May 29, 2026Jun 2 8:48 PMTracey L MccainDirector
Option Exercise
2,799—0(D)

View →

May 29, 2026Jun 2 8:46 PMThomas MalleyDirector
Grant/Award
14,184$48.382,026(D)

View →

May 29, 2026Jun 2 8:46 PMThomas MalleyDirector
Option Exercise
2,799—0(D)

View →

May 29, 2026Jun 2 8:44 PMRichard S LevyDirector
Grant/Award
14,184$48.382,026(D)

View →

May 29, 2026Jun 2 8:44 PMRichard S LevyDirector
Option Exercise
2,799—0(D)

View →

May 29, 2026Jun 2 8:42 PMBradley G ColeDirector
Grant/Award
14,184$48.382,026(D)

View →

May 29, 2026Jun 2 8:42 PMBradley G ColeDirector
Option Exercise
2,799—0(D)

View →

May 29, 2026Jun 2 8:30 PMBAKER BROS. ADVISORS LPDirector
Grant/Award
72,948$48.3836,474(I)

View →

May 1, 2026May 5 8:54 PMJohn F. PaoliniCHIEF MEDICAL OFFICER
Option Exercise
58,424$10.3629,670(D)

View →

May 1, 2026May 1 8:32 PMSanj K PatelDirector, CHAIRMAN & CEO
Option Exercise
48,565$30.930(D)

View →

Apr 30, 2026Apr 30 10:33 PMSanj K PatelDirector, CHAIRMAN & CEO
Option Exercise
2,141$30.9348,565(D)

View →

Apr 29, 2026Apr 30 10:33 PMSanj K PatelDirector, CHAIRMAN & CEO
Option Exercise
22,544$30.9350,706(D)

View →

Apr 28, 2026Apr 30 10:33 PMSanj K PatelDirector, CHAIRMAN & CEO
Option Exercise
483,654$30.9373,250(D)

View →

Apr 28, 2026Apr 29 8:46 PMBarry D QuartDirector
Option Exercise
13,099$14.3313,237(D)

View →

Apr 7, 2026Apr 8 8:45 PMEben TessariCHIEF STRATEGY OFFICER
Option Exercise
2,726—0(D)

View →

Apr 7, 2026Apr 8 8:44 PMMark RagosaCHIEF FINANCIAL OFFICER
Option Exercise
2,694—0(D)

View →

Apr 7, 2026Apr 8 8:43 PMSanj K PatelDirector, CHAIRMAN & CEO
Option Exercise
9,991—0(D)

View →

Apr 6, 2026Apr 8 8:43 PMSanj K PatelDirector, CHAIRMAN & CEO
Option Exercise
7,278$10.36431,904(D)

View →

Apr 7, 2026Apr 8 8:41 PMJohn F. PaoliniCHIEF MEDICAL OFFICER
Option Exercise
2,497—0(D)

View →